425: HRZN, MRCC Update Merger Proxy Amid Lawsuits

Horizon Technology Finance and Monroe Capital Corporation have updated their joint proxy statement with new financial projections and disclosures following class action lawsuits challenging the merger.

Summary

• Monroe Capital Corporation (MRCC) filed a Form 425 to supplement and update its joint proxy statement regarding a proposed asset sale to Monroe Capital Income Plus Corporation (MCIP) and a subsequent merger with Horizon Technology Finance Corporation (HRZN).
• The update addresses putative class action complaints filed against HRZN and its Board, alleging materially misleading and incomplete disclosures in the original Joint Proxy Statement.
• HRZN and the individual defendants deny the allegations but are voluntarily providing supplemental disclosures to reduce litigation costs and risks, without admitting liability or wrongdoing.
• The HRZN Board, including independent directors, unanimously recommends stockholders vote for the Merger Stock Issuance Proposal and the Director Election Proposal.
• The supplemental disclosures include unaudited forecasted financial information for MRCC and HRZN on a standalone basis, and for the combined company pro forma for the transactions, covering estimated Net Investment Income Per Share, Dividend Per Share, and Net Asset Value Per Share from 2026 to 2030.
• The disclosures also clarify Oppenheimer's past financial advisory services, stating that in the past two years, Oppenheimer has not received compensation for investment banking or financial advisory services to HRZN or MRCC.
• The supplemental disclosures will not affect the merger consideration or the timing of the special meeting scheduled for March 13, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive. While the class action lawsuits introduce a negative element, the company's proactive response with supplemental disclosures and the reaffirmation of the board's unanimous recommendation for the merger help to mitigate uncertainty and keep the transaction on track. The pro forma financial projections also suggest long-term benefits from the merger.

Positives

• The HRZN Board, including all independent directors, unanimously recommends stockholders vote for the Merger Stock Issuance Proposal and the Director Election Proposal, indicating strong internal support for the transaction.
• The voluntary supplemental disclosures aim to reduce litigation costs and risks, potentially clearing a path for the merger to proceed without further legal hurdles.
• Pro forma projections for the combined company show an increasing trend in Estimated Net Investment Income Per Share from $1.05 in 2026 to $1.24 in 2030, suggesting potential long-term value creation.
• The Estimated Dividend Per Share for the combined company is projected to remain stable at $1.00 from 2026 to 2030.
• Pro forma Estimated Net Asset Value Per Share for the combined company is projected to increase from $6.55 in 2026 to $7.89 in 2030.

Negatives

• The existence of putative class action complaints alleging materially misleading and incomplete disclosures in the original Joint Proxy Statement introduces legal uncertainty and potential costs.
• While HRZN denies the allegations, the need for voluntary supplemental disclosures suggests a perceived vulnerability or a strategic decision to avoid prolonged litigation, which could imply some merit to the plaintiffs' claims or at least a significant nuisance factor.
• The standalone projections for MRCC show a slight decrease in Estimated Net Investment Income Per Share from $0.31 in 2026 to $0.26 in 2027, before recovering, and a similar dip in Estimated Dividend Per Share, which might indicate challenges for MRCC on its own.
• The pro forma Estimated Net Asset Value Per Share for the combined company in 2026 ($6.55) is slightly lower than HRZN's standalone estimated NAV Per Share for the same year ($6.60), though it grows significantly thereafter.

Risks

• Uncertainties associated with the timing or likelihood of the proposed transactions closing.
• Risks that one or more closing conditions may not be satisfied or waived, including governmental entity approval or shareholder approvals.
• The possibility that competing offers or acquisition proposals for either company will be made.
• Risks related to diverting management's attention from ongoing business operations due to the merger process.
• The possibility that the expected synergies and savings associated with the proposed transactions may not be fully realized.
• The risk that shareholder litigation in connection with the proposed transactions may result in significant costs of defense and liability.
• Changes in the economy, financial markets, and political environment, including the impacts of inflation and interest rates.
• Risks associated with possible disruption in operations or the economy due to terrorism, war, natural disasters, tariffs, or public health crises.
• Future changes in laws or regulations, including their interpretation by regulatory authorities.
• Conditions in the operating areas of business development companies or regulated investment companies.

Future Outlook

The filing provides forward-looking projections for both standalone MRCC and HRZN, and for the combined entity post-merger, through 2030. These projections anticipate stable to growing Net Investment Income Per Share, consistent dividends, and increasing Net Asset Value Per Share for the combined company, reflecting expected cost savings and synergies from the merger. However, these are based on assumptions as of June 30, 2025, and are subject to significant risks and uncertainties, with no assurance that actual results will align with these forecasts.

Management Comments

• HRZN and the individual defendants believe that HRZN has previously disclosed all information required to be disclosed to ensure that its stockholders can make an informed vote at the Special Meeting and that the additional disclosures requested by the plaintiffs are not required under applicable law.
• HRZN and the individual defendants believe the claims asserted in the Merger Complaints are without merit.
• In order to reduce the costs, risks and uncertainties inherent in litigation, and without admitting any liability or wrongdoing, HRZN has determined voluntarily to revise and supplement the Joint Proxy Statement.
• Nothing in this Report shall be deemed an admission of the legal necessity or materiality under applicable laws of any of the disclosures set forth herein. To the contrary, HRZN and the HRZN Board specifically deny all allegations in the Merger Complaints that any additional disclosure was or is required.
• ON THE RECOMMENDATION OF A SPECIAL COMMITTEE OF THE HRZN BOARD, COMPRISED OF THE INDEPENDENT DIRECTORS OF THE HRZN BOARD, THE HRZN BOARD HAS UNANIMOUSLY RECOMMENDED THAT HRZN STOCKHOLDERS VOTE FOR THE MERGER STOCK ISSUANCE PROPOSAL.
• IN ADDITION, THE HRZN BOARD, INCLUDING ALL OF ITS INDEPENDENT DIRECTORS, HAS UNANIMOUSLY RECOMMENDED THAT HRZN STOCKHOLDERS VOTE FOR THE DIRECTOR ELECTION PROPOSAL.

Industry Context

StockSavvy.ai notes that the business development company (BDC) sector frequently sees consolidation efforts as companies seek scale, operational efficiencies, and diversified portfolios. This proposed merger between HRZN and MRCC, two BDCs, aligns with this trend, aiming to leverage combined strengths and achieve cost synergies. The legal challenges, while not uncommon in large corporate transactions, highlight the increasing scrutiny on disclosure practices and corporate governance within the financial industry, particularly concerning shareholder rights and transparency in merger processes. The voluntary supplemental disclosures by HRZN, despite denying the merits of the lawsuits, reflect a pragmatic approach to mitigate litigation risks and ensure the transaction proceeds, a common strategy in complex M&A environments.

Comparison to Industry Standards

• The projected stable dividend of $1.00 per share for the combined HRZN-MRCC entity from 2026-2030 is a key metric for BDCs, which are often valued for their income generation. This stability, if achieved, would compare favorably to BDCs that experience dividend volatility.
• The projected growth in Net Investment Income Per Share and Net Asset Value Per Share for the combined entity suggests a potential for enhanced shareholder value post-merger, which is a primary driver for BDC consolidations. For instance, larger BDCs like Ares Capital Corporation (ARCC) or Golub Capital BDC, Inc. (GBDC) often demonstrate economies of scale and broader access to deal flow, which the combined HRZN-MRCC entity aims to replicate.
• The voluntary supplemental disclosures in response to shareholder lawsuits, while denying wrongdoing, reflect a standard practice among publicly traded companies to address legal challenges and maintain investor confidence, similar to how other BDCs or financial institutions might handle M&A-related litigation to avoid delays or injunctions.

Corporate Governance

Legal Proceedings

• Putative class action complaint filed on January 30, 2026, in the Court of Chancery of the State of Delaware against HRZN and certain members of its Board of Directors.
• Two additional complaints with substantially similar allegations filed in the Supreme Court of the State of New York against HRZN and the HRZN Board.
• Allegations include materially misleading and incomplete disclosures in the combined definitive joint proxy statement.
• Complaints seek supplemental disclosures and an injunction against the closing of the Merger.
• HRZN is voluntarily providing supplemental disclosures to reduce litigation costs, risks, and uncertainties, without admitting liability or wrongdoing.

Related Party Transactions

• Asset Purchase Agreement dated August 7, 2025, between MRCC, MC Advisors (investment adviser to MRCC), and Monroe Capital Income Plus Corporation (MCIP), involving the sale of MRCC's investment assets and liabilities to MCIP for cash. MCIP is likely an affiliate of Monroe Capital/MC Advisors.

Stakeholder Impact

• Shareholders (MRCC & HRZN): Will vote on the merger proposals. HRZN shareholders will receive HRZN stock as merger consideration. The supplemental disclosures aim to provide more information for informed voting. Pro forma projections suggest potential long-term value growth and stable dividends for combined company shareholders.
• Customers/Portfolio Companies: The asset sale involves transferring MRCC's investment assets to MCIP, and the merger will combine the financial structures of MRCC and HRZN. This could lead to changes in how portfolio companies are managed or financed, potentially impacting their relationships with the new entity.

Next Steps

• HRZN stockholders to vote on the Merger Stock Issuance Proposal and the Director Election Proposal at the Special Meeting on March 13, 2026.
• Consummation of the Asset Sale by MRCC to MCIP.
• Completion of the Initial Merger (Merger Sub into MRCC).
• Completion of the Second Merger (MRCC into HRZN).

Key Dates

Recommendation

The filing provides crucial updates regarding a significant merger, including new financial projections and a response to shareholder lawsuits. While the board's unanimous recommendation and the projected long-term growth for the combined entity are positive, the ongoing litigation introduces a degree of uncertainty. The voluntary supplemental disclosures, while mitigating risk, also acknowledge the seriousness of the legal challenges. An investor would likely 'hold' to observe the outcome of the shareholder vote and the resolution of the legal proceedings, as well as to assess the market's reaction to the updated information and the eventual closing of the merger. The long-term projections are promising, but the immediate future carries execution and legal risks.

Keywords

Monroe Capital Corporation, MRCC, Horizon Technology Finance Corporation, HRZN, Merger, Asset Sale, SEC Filing, Proxy Statement, Class Action Lawsuit, Financial Projections, Net Investment Income, Dividend, Net Asset Value, Corporate Governance, BDC, Business Development Company